𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Peripheral blood leukocytes of patients with argentine hemorrhagic fever as effectors of antibody-dependent cell-cytotoxicity

✍ Scribed by Ana M. Ambrosio; Graciela S. Gamboa; María R. Feuillade; Ana M. Briggiler; M. T. Rimoldi


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
475 KB
Volume
37
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Peripheral blood mononuclear cells (PBMC) and polymorphonuclear leukocytes (PMNL) of patients with Argentine hemorrhagic fever (AHF) were tested as effectors (E) of antibody‐dependent cell cytotoxicity (ADCC). ^51^Cr labeled chicken red blood cells (CRBC) coated with anti‐CRBC or normal rabbit serum were used as targets (T).

Three ADCC assays were performed with both effectors from patients: on admission (I), 4 days after the transfusion of immune plasma (II), and 30 days after the clinical onset (III). The ADCC values obtained displayed high variation between individuals. From the linear portions in the curves representing specific ^51^Cr release vs. E:T ratio plots, extrapolations were made t o determine lytic units (LU), defined here as effector concentrations required t o lyse 50% of the targets. The results were expressed as LU in 106 effector cells.

The killing activity ranges of patients' PMNL (I = 1.04 ± 0.34; II = 2.22 ± 0.66; and III = 2.08 ± 1.18) were not significantly different from that of 21 normal controls (1.19 ± 0.361), except for range II (P < 0.01 1).

ADCC activity ranges of patients' PBMC (I = 3.40 ± 1.06; II = 3.16 ± 1.60; and III = 1.93 ± 0.42) were not significantly different from that determined in 12 healthy subjects (1.86 ± 0.40).

These results demonstrate that patients' PBMC and PMNL can perform ADCC with efficiency comparable to normal effector cells, during the acute period of AHF, and in early convalescence. Consequently, ADCC can be a relevant mechanism in the clearance of Junin virus‐infected cells.


📜 SIMILAR VOLUMES


Natural killer (NK) cells as effectors o
✍ Myung-Whun Sung; Satoshi Yasumura; Jonas T. Johnson; Guus A. M. S. Van Dongen; T 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 939 KB

In patients with cancer, antibody-dependent cellular cytotoxicity (ADCC) may be used as a laboratory test or for enhancing immunotherapy with murine monoclonal or chimeric mouse/ human anti-tumor antibodies (mMAbs or cMAbs, respectively). We have established an ADCC assay with lgG, cMAb SF-25, using